Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“Happy to have been invited to travel so far from home and bring all the work we’re doing in Marseille with our teams at the CRCM – Centre de Recherche en Cancérologie de Marseille and the Institut Paoli-Calmettes to the Cancer Cell Plasticity and Precision Oncology Symposium on December 1–2, 2025, at the University of Melbourne.
I’ll be speaking on December 2 at 10:40 AM, presenting: ‘Mapping PDAC Evolution to Overcome Therapeutic Resistance: A Signature-Driven Precision Oncology Approach.’ Speaking about how transcriptomic signatures can map PDAC evolution and help us understand and overcome therapeutic resistance.
Science only moves forward when we collaborate, share openly, and work together across countries and disciplines. It’s not only the most effective way to make progress, it’s also the most beautiful part of this job.
Looking forward to meeting everyone there and contributing in my small way.”
More posts featuring Nelson Dusetti.